Key points are not available for this paper at this time.
Our results suggested that glutamine metabolism is involved in the pathogenesis of RA and that GLS1 plays an important role in regulating RA-FLS proliferation, and may be a novel therapeutic target for RA.
Takahashi et al. (2017) studied this question.